Ulcerative Proctitis vs Ulcerative Colitis

Ulcerative proctitis is ulcerative colitis that stays in the rectum. It is not a cousin of UC or a milder relative with a different name: it is the same disease, caught at its shortest extent, and gastroenterologists file it as E1 in the Montreal classification (Satsangi 2006). What changes with extent is how it is treated, how often it spreads, and how much it raises the long-term risks that people with UC worry about.

If you have just been told "it's proctitis, the good kind", you probably came away with more questions than answers. That is exactly what people describe in r/UlcerativeColitis: one newly diagnosed person wrote that every doctor seemed rushed, that one told them the disease would spread and cost them their bowel if they missed a single pill, and that they did not know what maintenance would even look like (r/UlcerativeColitis). This article is the conversation that appointment did not have time for.

Is ulcerative proctitis the same as ulcerative colitis?

Yes. Ulcerative proctitis is ulcerative colitis in which the inflammation is limited to the rectum, ending below the junction where the rectum meets the sigmoid colon. It is the same disease with the same relapsing course. The only defining difference is how far up the bowel the inflammation reaches, which is why doctors classify UC by extent.

The international system most clinics use is the Montreal classification, agreed by a working party in 2005 (Satsangi 2006). It sorts ulcerative colitis into three groups by the maximum extent of inflammation ever seen:

Two words cause most of the confusion. Proctitis on its own simply means an inflamed rectum, from any cause, so a report that says "proctitis" is not automatically a UC diagnosis. Proctosigmoiditis (sometimes "rectosigmoiditis") means the inflammation has crept just into the sigmoid colon, and under Montreal that counts as E2, left-sided colitis, even though many people with it think of themselves as having proctitis. If your report uses either term, it is reasonable to ask your gastroenterologist exactly which Montreal group you are in.

The working party also made a rule that matters later: your classification is the maximal extent ever recorded. If a later colonoscopy shows the inflammation has shrunk back, you are still filed at the highest extent you have had (Satsangi 2006).

What is the difference between ulcerative proctitis and ulcerative colitis?

The practical differences are extent, treatment route, how often symptoms spill over into the whole body, and long-term risk. Proctitis is usually treated with suppositories, rarely leads to colectomy, and does not clearly raise bowel cancer risk. Extensive colitis is more often treated with tablets or advanced therapies and carries the highest long-term risks.

Here is the side-by-side, with each figure sourced in the sections below:

The population figures come from a systematic review of 17 inception cohorts covering 15,316 adults with UC. At diagnosis, 29.4% had proctitis and 30.5% had extensive colitis, with left-sided disease the most common. Ten-year colectomy risk was 19% for extensive colitis, 8% for left-sided colitis and 5% for proctitis, and extraintestinal manifestations were reported in 15% of people with left-sided or extensive disease compared with 6% of people with proctitis (Fumery 2018).

What the table cannot show is how it feels. That is where the "proctitis is the easy one" framing breaks down, so the next section deals with symptoms.

What are the symptoms of ulcerative proctitis compared with extensive UC?

Proctitis mostly produces rectal symptoms: blood, mucus, urgency, the feeling of needing to go with little coming out, and sometimes constipation. Extensive colitis more often adds frequent loose stools, abdominal pain and whole-body effects such as fever or weight loss. The overlap is large, and symptom severity alone cannot tell you the extent.

When someone in r/UlcerativeColitis asked people with mild proctitis to list their symptoms, the replies clustered around the same handful: mucus, blood, random urgency, a burning or "bubbling" feeling in the rectum, cramps, loud gut noises, and in several cases constipation rather than diarrhoea. A few described stools that were normal or nearly normal, with blood and mucus as the only sign (r/UlcerativeColitis).

The best recent data come from a cross-sectional survey of physicians and their patients in France, Germany, Italy, Spain, the UK and the US, comparing 221 people with isolated proctitis against 1,607 with more extensive UC. Abdominal pain was reported in 33.8% of the proctitis group and 26.0% of the extensive group, bowel urgency in 22.7% and 23.6%, and fatigue in 22.7% and 23.8%. Physicians also commonly recorded passing mucus (19.0%), tenesmus (15.7%) and rectal bleeding (15.3%) in the proctitis group (Armuzzi 2026). In other words, on several symptoms people with proctitis looked no better off than people with more extensive disease. Three of the authors are Pfizer employees and the data came from a commercial survey programme to which Pfizer subscribes; the paper states Pfizer did not influence the survey design or data collection.

Three proctitis symptoms are confusing enough that we have written about each separately:

• Tenesmus, the urge to empty a rectum that is already empty, is covered in ulcerative colitis tenesmus.
• Urgency and how to get it under control is in how to stop urgency with ulcerative colitis.
• Constipation with an inflamed rectum, which surprises many newly diagnosed people, is in constipation with ulcerative colitis.

The Montreal working party's definition of mild UC, four or fewer stools a day with no systemic illness and normal inflammatory markers (Satsangi 2006), is a useful reminder of what is not expected. Fever, weight loss, a racing pulse or six or more bloody stools a day do not fit "just proctitis" and need prompt review.

Can proctitis be something other than ulcerative colitis?

Yes. An inflamed rectum can come from sexually transmitted infections, other infections, radiation treatment, a bypassed rectum after stoma surgery, reduced blood supply, and some medicines. Ulcerative proctitis is diagnosed only when the biopsies fit UC and these other causes have been considered, which is why repeat testing sometimes changes the label.

British guidance on IBD lists the things to exclude when proctitis does not respond to standard treatment: infections including lymphogranuloma venereum, gonorrhoea, herpes simplex, syphilis, Giardia and amoebiasis, plus solitary rectal ulcer, chemical colitis and rectal prolapse (Lamb 2019). A review of sexually transmitted proctitis written for gastroenterologists describes gonorrhoea, chlamydia, herpes, syphilis, giardiasis and amoebiasis as causes that can present with proctitis and need distinguishing from inflammatory bowel disease (Lamb 2013).

This is not theoretical. In one of the threads above, a reader with a proctitis diagnosis wrote that a positive chlamydia test had thrown their UC diagnosis into question and urged others to be tested (r/UlcerativeColitis). We cannot verify that person's case, and a positive test does not by itself rule out UC, but asking about STI testing is quick and reasonable, especially if you have had receptive anal sex. Our post on what can be mistaken for ulcerative colitis covers the look-alikes in more depth.

Does ulcerative proctitis spread, and how often does it turn into colitis?

It can. In most studies, roughly a fifth to a third of people diagnosed with proctitis are later found to have inflammation further up the colon, mostly within the first ten years. Spread all the way to extensive colitis is less common, around 10% to 18% in population and pooled data. Most people with proctitis never reach extensive colitis.

The reason you have seen numbers anywhere from 10% to 54% is that different sources measure different things. Here are the main ones, side by side:

Three points help put all this in proportion.

Most extension is to the left side, not the whole colon. In every source that splits the two, moving from E1 to E2 is more common than moving from E1 to E3. British guidance recommends oral mesalamine as first-line treatment for mild to moderate ulcerative colitis beyond the rectum (Lamb 2019), so extension does not automatically mean a stronger class of medicine.

Extension is not a one-way street. The Montreal working party noted that disease extent can also regress over time, with published regression estimates ranging very widely (Satsangi 2006). This is part of why your label is fixed at the maximum extent ever seen.

Where you live and how old you are seem to matter. The 2017 meta-analysis found extension was more common in people diagnosed under 18 (29.2% against 20.2%) and in North American studies (37.8%) than in European ones (19.6%) (Roda 2017). The authors did not establish why; differences in how often people were re-scoped could contribute.

Reddit is full of both outcomes. In one thread asking how often proctitis "turns into worse", people described decades of stable proctitis, proctitis that stayed put for years and then extended, and a few who were re-scoped within months and found pancolitis (r/UlcerativeColitis). Bear in mind that people whose disease stays quiet are less likely to be posting in a support forum, as one commenter in that thread pointed out.

What makes proctitis more likely to spread?

The factors linked to spread are mostly markers of more active disease: frequent relapses, needing steroids or immunosuppressants, failing first treatment, more severe inflammation at diagnosis and younger age. Not smoking was also associated with spread in one large study. These are associations, so they help predict who needs closer follow-up rather than proving what causes extension.

The individual findings:

• Frequent relapses and stronger treatment. In the GSMII cohort, extension was more likely in people with more than three relapses a year, people who needed systemic steroids or immunosuppressants, and non-smokers; refractory disease stood out as an independent predictor (Meucci 2000).
• Severity at diagnosis. In the Brazilian cohort, younger age (under 40), a higher Mayo endoscopic score, a higher partial Mayo score and use of oral steroids at diagnosis were linked to later pancolitis, and those who extended had more relapses and more colectomies (Da Costa Ferreira 2022).
• Not settling early. A cohort of people with newly diagnosed limited UC (proctitis or left-sided) defined initial treatment failure as no remission within three months, or a relapse within three months of remission. That group had about three times the hazard of proximal extension, after statistical matching (Sato 2026).

The smoking finding deserves a careful word. It fits a long-observed pattern in ulcerative colitis, but it is not a reason to smoke, and we cover the trade-offs fully in does smoking help ulcerative colitis.

Can you prevent spread by taking your medicine? This is the question newly diagnosed people ask most, and the honest answer is that it is plausible but unproven. The studies above show that people whose disease is harder to control are more likely to extend. They do not show that maintenance treatment in people who are already well controlled prevents extension, because no trial we found randomised people with proctitis to maintenance or no maintenance and followed extension as the outcome. What maintenance treatment clearly does is reduce relapses, which is covered below.

What is a "caecal patch", and does it mean the disease has spread?

Sometimes a colonoscopy report for someone with distal colitis mentions inflammation around the appendix opening in the caecum, far from the rectum, with normal-looking bowel in between. In a small study of 20 people with left-sided UC who had full colonoscopy with biopsies, 15 (75%) had this kind of patchy inflammation, and it always included the area around the appendix opening (D'Haens 1997). It is a recognised feature, not automatically a sign of Crohn's disease or of extension. In a single-centre cohort of 230 people with proctitis, having a caecal patch made no difference to whether the disease became refractory (Borkovsky 2026). If your report mentions one, ask your team how they are classifying it.

Why are suppositories and enemas used for proctitis instead of pills?

Because rectal medicine goes straight to the inflamed lining. British guidance recommends a mesalamine (5-ASA) suppository as first-line treatment for mild or moderate ulcerative proctitis, noting that it reaches much higher concentrations in the rectum than tablets, and that suppositories are preferred to enemas because enemas tend to pool higher up, in the sigmoid colon.

That recommendation was graded strong, based on high-quality evidence, with 100% agreement among the guideline panel (Lamb 2019). The same guidance adds that:

• Topical mesalamine is more effective than a topical steroid.
• Adding oral mesalamine improves response, so people who do not respond fully to suppositories should have tablets added early.
• Using the suppository at bedtime is practical because it can be retained for longest.
• Steroid suppositories are an option for people who do not respond to, or cannot tolerate, mesalamine suppositories and tablets.

A systematic review of 32 randomised trials in ulcerative proctitis (27 induction trials with 2,839 participants and 5 maintenance trials with 334) confirmed topical mesalamine for both getting and staying in remission. In the trials that tested a combination, topical steroid plus mesalamine produced a response more often than either alone (Caron 2022). A 337-patient trial found a budesonide suppository at its higher strength performed similarly to a standard mesalamine suppository for symptom resolution, giving another rectal option (Kruis 2019); we could not read a funding statement for that trial.

This is where proctitis and extensive colitis really do differ. For mild to moderate UC that reaches beyond the rectum, the same guidance recommends oral mesalamine as the starting point instead (Lamb 2019). One reader with proctitis described asking for suppositories during a flare because the drug goes straight to the spot rather than travelling through the intestines first (r/UlcerativeColitis). That is consistent with the guideline reasoning, though it is one person's experience.

Will I need medication every day for proctitis?

Not necessarily, but most people do better with some maintenance. Placebo-controlled trials show regular mesalamine suppositories greatly reduce relapse in proctitis. British guidance also accepts that some people with infrequent flares restart suppositories only when a flare begins, because cancer risk in proctitis is similar to the general population. The choice is yours to make with your IBD team.

The maintenance evidence is old but consistent:

• In an Italian trial of 111 people with proctitis in remission, the cumulative relapse rate at 12 months was 10% with suppositories used twice a day, 32% with once a day, and 47% with placebo (d'Albasio 1998).
• In a second trial of 65 people over 24 months, relapse at 12 months was 86% on placebo against 32% on nightly mesalamine suppositories, and at 24 months 89% against 46% (Hanauer 2000). The trial was of a named branded product; we could not read a conflict-of-interest statement for it.

On the alternative, British guidance says many people respond promptly to suppositories and, if flares are infrequent, are happy to start them when a flare begins rather than take regular maintenance, and that this is quite safe because colorectal cancer risk in proctitis is similar to that of the general population. It also notes that alternate-night or every-third-night use does not seem to reduce the maintenance benefit much, and that some people prefer oral therapy to long-term rectal treatment (Lamb 2019).

The Reddit threads show both sides of this decision. Several people described years of remission on suppositories alone, or keeping a supply in the cupboard for the first sign of trouble. Others described stopping mesalamine once they felt well and then flaring badly enough to need stronger treatment, and said they regretted it (r/UlcerativeColitis). Neither story proves what will happen to you. They do illustrate why this is a decision to plan, not to drift into.

What if proctitis does not respond to treatment?

This is refractory proctitis, and it is more common than the "mild form" label suggests. In recent cohorts, between about a fifth and a third of people with proctitis did not settle on mesalamine and went on to immunosuppressants or advanced therapies. Before escalating, guidelines say to check adherence, confirm the diagnosis and look for constipation above the inflamed rectum.

The recent numbers:

• In an Australian cohort of 185 people with proctitis, 30.3% developed refractory disease. Among those, treatment success was achieved in 45% of people given immunomodulators and 59% of people given advanced therapies. Having refractory proctitis was strongly associated with hospitalisation and other complications (Raja 2026).
• In a single-centre cohort of 230, 21.7% were classed as refractory. In the adjusted analysis, needing topical steroids and having more severe endoscopic inflammation at diagnosis predicted refractory disease (Borkovsky 2026).
• In the six-country survey, 21.3% of people with isolated proctitis had received an immunomodulator and 33.5% an advanced therapy after diagnosis. Only 40.3% were in remission at the time of the consultation, and the share was lowest, 35.0%, among those who had already needed stronger treatment (Armuzzi 2026).

British guidance's checklist before escalation is worth knowing because it puts the simple causes first: make sure conventional therapy was actually delivered (including adherence), make sure the diagnosis is right, and look for proximal constipation and coexisting irritable bowel syndrome, both of which can drive symptoms and poor response. If those are excluded and standard treatment has failed, a thiopurine can be added with escalation to biologics if there is no response (Lamb 2019).

There are also other rectal options for 5-ASA-refractory proctitis. A Dutch and Belgian randomised trial of 85 people found tacrolimus and beclomethasone suppositories produced similar clinical response after four weeks, 63% and 59% (Lie 2020).

The authors of the Australian cohort named this the "proctitis paradox": a short segment of inflammation that can still produce disabling symptoms and complications (Raja 2026). If you have been made to feel you are overreacting to "only proctitis", that phrase is a useful one to bring to your next appointment.

Is ulcerative proctitis serious? Cancer and colectomy risk

By the outcomes that define serious long-term risk, proctitis is the least dangerous form of ulcerative colitis while it stays in the rectum. Bowel cancer risk is not clearly raised, British guidance does not recommend ongoing surveillance colonoscopy for it, and ten-year colectomy risk in population cohorts is about 5%. The burden of symptoms can still be heavy.

Cancer. A classic population-based study followed 3,117 people with UC. The standardised incidence ratio for colorectal cancer was 1.7 for proctitis, with a 95% confidence interval of 0.8 to 3.2, compared with 2.8 for left-sided colitis and 14.8 for pancolitis (Ekbom 1990). A confidence interval that includes 1 means the study could not show any increase for proctitis. A much later French cohort of 19,486 people with IBD found that people without long-standing extensive colitis had a colorectal cancer risk similar to the general population (Beaugerie 2013), and the 2018 population review concluded risk was raised in pancolitis and left-sided colitis but not in proctitis (Fumery 2018).

That is why British guidance says people with proctitis and no evidence of proximal progression do not need ongoing surveillance colonoscopy (Lamb 2019). The same guidance advises people with left-sided or more extensive UC to take mesalamine partly to reduce colorectal cancer risk, a recommendation it frames around left-sided and extensive disease rather than proctitis. The important qualifier is "no evidence of proximal progression". If your disease extends, your risk and your surveillance schedule change, which is one more reason to report a change in symptoms rather than assume it is the same old proctitis.

Colectomy. Ten-year colectomy risk was about 5% for proctitis, against 8% for left-sided and 19% for extensive colitis, in population-based cohorts (Fumery 2018). In the 2026 Australian cohort, only one of 185 people with proctitis had a colectomy over a median of about four years (Raja 2026). The abstract prints that as 0.05%; one in 185 is about 0.5%. If you want to understand what pushes someone toward surgery, see how do you know if you need a colectomy.

Day-to-day burden. This is the part the low risk numbers hide. The six-country survey found people with proctitis reporting abdominal pain, urgency and fatigue at rates similar to or higher than people with more extensive disease (Armuzzi 2026). Low long-term risk and a hard daily life can both be true.

Why might calprotectin look lower with proctitis?

Faecal calprotectin, the stool test for bowel inflammation, tends to read lower in proctitis than in more extensive colitis at the same level of endoscopic activity, because less inflamed lining is shedding into the stool. It still tracks healing well, so the practical lesson is to compare your result with your own previous results rather than with someone else's.

In a single-centre study of 518 visits by 254 people with UC, median calprotectin in endoscopically active disease was 440 µg/g in proctitis, 840 in left-sided colitis and 1,690 in pancolitis. In inactive disease it was 24 µg/g in proctitis against 85 in pancolitis. Despite that, the test distinguished mucosal healing equally well across all three extents (Steinsbø 2025). The study was supported by unrestricted grants from AbbVie and Tillotts Pharma, which the authors state did not influence the research.

The American Gastroenterological Association's biomarker guideline also suggests endoscopic assessment, rather than relying on a biomarker, for people with UC who have mild symptoms (Singh 2023), which describes a lot of people with proctitis. A short flexible sigmoidoscopy is often enough to see the rectum. For how calprotectin results are usually read in UC, see what do calprotectin levels mean for ulcerative colitis, or put your own number into the explainer below.

Is there a special diet for ulcerative proctitis?

No diet has been shown to treat ulcerative proctitis specifically. We found no dietary trial limited to people with proctitis, and dietary guidance for UC is not split by extent. Many people do find certain foods worsen urgency or discomfort during a flare, which is worth noticing and discussing with a dietitian rather than cutting foods indefinitely.

"Ulcerative proctitis diet" is one of the most common searches around this condition, and the threads show why: people describe cutting sugar, gluten, dairy or additives and feeling better, while others are emphatic that diet did not control their inflammation and medication did (r/UlcerativeColitis). Both experiences are real, and because proctitis naturally comes and goes, it is easy to credit a diet change with a remission that would have happened anyway. For what the UC evidence does say, see what to eat during a UC flare. If you have proctitis with constipation, the advice is different again, and is covered in the constipation post.

Can ulcerative proctitis go away?

Symptoms can go away for months or years, sometimes without any treatment. The inflamed area can also shrink. But proctitis is a form of ulcerative colitis, a chronic condition that tends to relapse, so the goal is long remission rather than a cure, and your diagnosis stays on file at its maximum extent.

In the population cohorts, the cumulative risk of relapse in ulcerative colitis overall was 70% to 80% at ten years (Fumery 2018). That figure is not specific to proctitis, but it shows why "it has gone, I can forget about it" is a risky assumption. One reader described having mild proctitis that went quiet with treatment, followed by years off medication before a second, more extensive flare (r/UlcerativeColitis). Others in the same thread have had stable proctitis for well over a decade. Planned follow-up is how you find out which pattern you are in.

What to track if you have proctitis

The useful things to track are the ones that tell your team whether proctitis is controlled or changing: bleeding days, urgency, stool form, how often you go, how you are using rectal treatment, and any new symptoms that do not fit proctitis. Writing these down turns "it has been worse lately" into something your gastroenterologist can act on.

A short daily log covers most of it:

1. Bleeding: none, streaks, or more, and on how many days.
2. Urgency and tenesmus: how often you had to rush, and whether you passed stool or only blood and mucus.
3. Stool form and frequency: including hard stools, since constipation above an inflamed rectum is a known cause of poor response.
4. Rectal treatment: whether you used it, and whether you kept it in.
5. Anything new: loose stools many times a day, abdominal pain away from the rectum, night-time symptoms, fever or weight loss. These are the signals that do not fit proctitis and may mean more active or more extensive disease.
6. Test results: each calprotectin result with its date and laboratory.

If you want a structure, our guide to what to track in an IBD symptom diary has field definitions that line up with the scores clinicians use, and how do I know if my ulcerative colitis is flaring explains how to tell a flare from a bad day. Clairop can log bowel movements, blood and urgency in a few taps and turn them into a one-page report for your appointment; you can see how it works. It does not diagnose or classify your disease.

Myths about ulcerative proctitis

"Proctitis isn't real colitis." It is ulcerative colitis, classified as E1. The only defining difference is extent (Satsangi 2006).

"Proctitis always turns into pancolitis eventually." Most people with proctitis do not develop extensive colitis. Population and pooled estimates for spread all the way to E3 run from about 10% at ten years in the GSMII cohort to 17.8% in the meta-analysis, with one referral-centre series reporting 29.9% (Meucci 2000; Roda 2017; Da Costa Ferreira 2022).

"If you miss one pill, it will spread and you will lose your colon." No study we found shows that a missed dose causes extension, and colectomy for proctitis is uncommon. Regular treatment does reduce relapse, which is a good enough reason to take it.

"Mild means it shouldn't bother me much." Mild refers mainly to extent and long-term risk. People with proctitis report urgency, pain and fatigue at rates similar to people with more extensive colitis (Armuzzi 2026).

"Tablets are a stronger treatment than suppositories." For disease confined to the rectum, guidance recommends suppositories first because they deliver more drug where it is needed (Lamb 2019).

"Proctitis needs yearly cancer checks like the rest of UC." British guidance says proctitis with no proximal progression does not need ongoing surveillance colonoscopy (Lamb 2019). That changes if the disease extends.

When to see a doctor promptly

See a doctor promptly for undiagnosed new rectal bleeding, bleeding that is heavier than your usual, more than six bloody stools a day, fever, unexplained weight loss, a fast heartbeat, dizziness, severe abdominal pain, symptoms waking you at night, or signs of anaemia such as breathlessness or marked tiredness. These do not fit mild proctitis.

Also contact your IBD team, rather than waiting for a routine appointment, if:

• Your usual treatment stops working, or a flare is not improving despite it.
• Your symptoms change character, for example from blood and mucus with formed stools to frequent loose stools or pain higher in the abdomen.
• You have pain around the anus with sores or discharge, or you think you may have been exposed to a sexually transmitted infection.
• You are struggling to use rectal treatment and have stopped.

Seek emergency care for severe abdominal pain with a swollen or tender abdomen, heavy bleeding, fainting, or persistent vomiting. If you are newly diagnosed and not sure what to ask, our list of questions to ask a gastroenterologist about colitis is a good place to start.

The honest bottom line

Ulcerative proctitis and ulcerative colitis are one disease at different extents. Proctitis is, on average, the gentlest version: rectal treatment works well for most people, colectomy is uncommon, and cancer risk is not clearly raised while it stays in the rectum. But averages hide a real minority whose proctitis spreads or will not settle, and the research on that group is thinner than it should be. The best protection is not worry about a percentage. It is a clear plan with your team for maintenance, a low threshold for reporting change, and a record of how you are actually doing between appointments.